$3.15
0.092.94%
At close: May 13, 5:00 PM EST
$3.17
0.020.63%
After Hours: 7:22 PM EST
Akari Therapeutics PLC Earnings Estimates
AKTXNASDAQ
Akari Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AKTX
Akari Therapeutics (AKTX) is scheduled to report Q1 earnings on May 26, 2026. Analysts estimate EPS of $-2.80 and quarterly revenue of N/A.
In the most recent quarter (Q4), Akari Therapeutics reported EPS of $0.00, beating estimates of $-2.80 by 1.00%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Akari Therapeutics has beaten EPS estimates in 3 consecutive quarters.
Over the last 3 quarters, Akari Therapeutics has averaged an EPS surprise of 1.00% and a revenue surprise of 0.00%.
Earnings Date
May 26
EPS Estimate
$-2.800
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Akari Therapeutics Earnings History
Analyze the earnings history of Akari Therapeutics using advanced sorting and filters.
Loading calendar...
Akari Therapeutics (AKTX) Earnings Per Share
The chart below shows Akari Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Akari Therapeutics (AKTX) Revenue
The chart below shows Akari Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Akari Therapeutics (NASDAQ:AKTX) reporting earnings?
Akari Therapeutics (AKTX) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on March 30, 2026 for Q4.
What were the latest earnings per share (EPS) for Akari Therapeutics (NASDAQ:AKTX)?
The Actual EPS was $0.00, which beat the estimate of $-2.80.
What were Akari Therapeutics’s (NASDAQ:AKTX) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
